From: Risk of valvular heart disease associated with use of fenfluramine
Author, year | Mean Age | Fen dose (mg/day) | Dexfen dose (mg/day) | Duration (months) | Time off (months) | Controls (N) | Affected in Controls | Exposed (N) | Affected in Exposed |
---|---|---|---|---|---|---|---|---|---|
Khan, 1998 | 45.3 | 90 | 30 | 20.6 | 3.9 | 233 | 0 | 233 | 2 |
Weissman, 1998 | 45.1 | 0 | 30 | 2.4 | 1.3 | 333 | 4 | 677 | 12 |
Shively, 1999 | 50.0 | 0 | 30 | 6.9 | 8.5 | 189 | 1 | 223 | 3 |
Hensrud, 1999 | 42.0 | 40 | 0 | 9.6 | 1.5 | 11 | 0 | 19 | 0 |
Ryan, 1999 | 49.1 | 60 | 30 | 16.7 | 12.2 | 0 | 0 | 79 | 1 |
Gardin, 2000 | 46.9 | 46 | 0 | 11.9 | 6.8 | 537 | 17 | 452 | 23 |
Gardin, 2000 | 48.4 | 0 | 29 | 6 | 5.3 | 472 | 23 | ||
Jollis, 2000 | 46.1 | 60 | 0 | 2 | 15 | 668 | 10 | 25 | 0 |
46.1 | 60 | 0 | 4.5 | 15 | 313 | 7 | |||
46.1 | 60 | 0 | 9 | 15 | 412 | 12 | |||
46.1 | 60 | 0 | 18 | 15 | 315 | 8 | |||
46.1 | 60 | 0 | 30 | 15 | 86 | 2 | |||
Davidoff, 2001 | 48.8 | 60 | 0 | 2.5 | 53 | 254 | 12 | 276 | 14 |